Angiotech enters distribution pact with B. Braun

Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company, has entered an exclusive five-year distribution agreement with B. Braun for its proprietary Quill SRS product line in the U.K., Ireland and France. Angiotech release

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.